Stimulation by Ang II reportedly activates NADPH oxidase and the MAPK pathway via these receptors, leading to oxidative stress-induced myocardial damage and cardiac hypertrophy [10]. This evidence concerns the gene FMO5 and cardiac hypertrophy.